Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Morgan

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2010
Cervical cancer screeningEdward E Partridge, Nadeem R Abu-Rustum, Susan M Campos, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2010
Cervical cancerBenjamin E Greer, Wui-Jin Koh, Nadeem R Abu-Rustum, et al.
NPJ Precision Oncology|March 6, 2025
LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarkerPamela R de Santiago, Sho Sato, Stephanie J Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Cervical cancerWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)Bradley J Monk, Christine Parkinson, Myong Cheol Lim, et al.
The New England Journal of Medicine|September 29, 2019
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian CancerRobert L Coleman, Gini F Fleming, Mark F Brady, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2010
Cervical cancer screeningEdward E Partridge, Nadeem R Abu-Rustum, Susan M Campos, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2010
Cervical cancerBenjamin E Greer, Wui-Jin Koh, Nadeem R Abu-Rustum, et al.
NPJ Precision Oncology|March 6, 2025
LINE-1 ORF1p expression occurs in clear cell ovarian carcinoma precursors and is a candidate blood biomarkerPamela R de Santiago, Sho Sato, Stephanie J Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Cervical cancerWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)Bradley J Monk, Christine Parkinson, Myong Cheol Lim, et al.
The New England Journal of Medicine|September 29, 2019
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian CancerRobert L Coleman, Gini F Fleming, Mark F Brady, et al.
Pageof 9